RFA-DP-24-062: Health Promotion and Disease Prevention Research Centers: 2024 Special Interest Project Competitive Supplements (SIPS)
Closed
This grant is closed. A newer notice from the same program is forecast: Health Promotion and Disease Prevention Research Centers: 2027 Special Interest Project Supplements (SIPS) (RFA-DP-27-030). Status: Expected deadline March 23, 2027. It is in our archive of Centers for Disease Control and Prevention - ERA notices from 2023.
Centers for Disease Control and Prevention - ERA offered grants of up to $675,000 to the applicants described in the notice. It expected to make about 28 awards worth $36.1 million in total. Applications closed on March 4, 2024.
From the official notice on Grants.gov, last changed December 15, 2023. Checked November 7, 2026.
- Award ceiling$675,000
- Total funding$36.1 million
- Expected awards28
- Cost sharingNot required
- Funding typeCooperative Agreement
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| RFA-DP-25-126 | December 12, 2024 | Closed February 28, 2025 | Closed |
| RFA-DP-22-003 | December 23, 2021 | Closed March 4, 2022 | Closed |
Key dates
| Posted | December 15, 2023 |
|---|---|
| Deadline | March 4, 2024 |
| Archived by Grants.gov | April 3, 2024 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Applicants must be approved for funding under CDC Notice of Funding Opportunity RFA-DP-24-004 Health Promotion and Disease Prevention Research Centers in order to apply for SIP supplemental funding under this announcement. On the SIP applicant's SF424 (R&R), the institution's legal name, EIN, and UEI (sections 8a, b and c of SF424) must match the information of the institution selected for funding under RFA-DP-24-004 as listed in the Notice of Award. Special eligibility may apply to each SIP that will be listed in the NOFO.
Is this a realistic fit?
- Past Centers for Research and Demonstration for Health Promotion and Disease Prevention awards averaged $2.0 million; this notice allows up to $675,000 per award.
- No cost sharing or match is required.
What the grant funds
This NOFO will provide supplemental funding to CDC Prevention Research Centers (PRCs) to conduct Special Interest Projects (SIPs). The purpose of the SIPs is to inform public health practice through high-quality applied health promotion and disease prevention public health research in real-world settings to identify, design, test, assess, evaluate, disseminate, and translate interventions (i.e. programs, practices, policies, or strategies) and tools or resources to prevent and reduce risk for the leading causes of illness, disability, and death in the United States. The 13 SIP proposals that will be included in this NOFO are listed below. Understanding the needs of ovarian cancer survivorsSurvivorship care plans and mortality among adult cancer survivorsCancer Prevention and Control Research Network (CPCRN)Gauging men’s reaction to relabeling of GG1 prostate cancer and understanding of pathology reportsUnderstanding the impact of reducing social isolation and loneliness on health indices among cancer survivors Nutrition Obesity Policy Research and Evaluation Network (NOPREN)Physical Activity Policy and Evaluation Research Network (PAPREN)Managing Epilepsy Well Network (MEW)Arthritis Management and Well-being Research Network (AMWRN)Mental Health and Chronic Disease Prevention Network (MHCDPN)Assessment of perceptions and effectiveness of interventions to increase MMR vaccination among children in close-knit communities with longstanding vaccine hesitancyAdvancing Research in Immunization Services Network (ARISe)Understanding the potential of schools in promoting non-mandating childhood vaccinations
Who has won Centers for Research and Demonstration for Health Promotion and Disease Prevention grants before
From fiscal 2021 to 2025, Centers for Research and Demonstration for Health Promotion and Disease Prevention (93.135) awarded $131 million across 67 grant awards, an average of $2.0 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Emory University | Georgia | 2 | $9.2 million |
| University of Washington | Washington | 1 | $7.8 million |
| New York University | New York | 3 | $7.3 million |
| University of North Carolina at Chapel Hill | North Carolina | 2 | $7.1 million |
| Regents of the University of Michigan | Michigan | 3 | $6.6 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, RFA-DP-27-030, which is forecast.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFA-DP-24-062 still open?
No. It closed on March 4, 2024. A newer notice is forecast: RFA-DP-27-030, expected deadline March 23, 2027.
Who can apply for Health Promotion and Disease Prevention Research Centers: 2024 Special Interest Project Competitive Supplements (SIPS)?
Centers for Disease Control and Prevention - ERA accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Health Promotion and Disease Prevention Research Centers: 2024 Special Interest Project Competitive Supplements (SIPS)?
Closed March 4, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $675,000 each. About $36.1 million in total across about 28 awards.
Who has won Centers for Research and Demonstration for Health Promotion and Disease Prevention grants before?
The largest recipients over five fiscal years were Emory University, University of Washington, New York University. The program made 67 awards worth $131 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)